Universitat de Barcelona-ko ikertzaileekin lankidetzan egindako argitalpenak (8)

2023

  1. Author Correction: Defective HNF4alpha-dependent gene expression as a driver of hepatocellular failure in alcoholic hepatitis (Nature Communications, (2019), 10, 1, (3126), 10.1038/s41467-019-11004-3)

    Nature Communications

2022

  1. Nivolumab after selective internal radiation therapy for the treatment of hepatocellular carcinoma: a phase 2, single-arm study

    Journal for immunotherapy of cancer, Vol. 10, Núm. 11

2021

  1. Assessing the impact of COVID-19 on liver cancer management (CERO-19)

    JHEP Reports, Vol. 3, Núm. 3

  2. Endothelial dysfunction markers predict short-term mortality in patients with severe alcoholic hepatitis

    Hepatology International, Vol. 15, Núm. 4, pp. 1006-1017

  3. Integrated Multiomics Reveals Glucose Use Reprogramming and Identifies a Novel Hexokinase in Alcoholic Hepatitis

    Gastroenterology, Vol. 160, Núm. 5, pp. 1725-1740.e2

  4. Loss of hepatocyte identity following aberrant YAP activation: A key mechanism in alcoholic hepatitis

    Journal of Hepatology, Vol. 75, Núm. 4, pp. 912-923

2020

  1. Exogenous Liposomal Ceramide-C6 Ameliorates Lipidomic Profile, Energy Homeostasis, and Anti-Oxidant Systems in NASH

    Cells, Vol. 9, Núm. 5

2019

  1. Defective HNF4alpha-dependent gene expression as a driver of hepatocellular failure in alcoholic hepatitis

    Nature Communications, Vol. 10, Núm. 1